BIO applauded Secretary of Agriculture Tom Vilsack’s announcement of four new BCAP project areas in six states that are expected to generate as many as 3,400 jobs in rural areas.
There are many examples of how genetically engineered (GE) animals can positively transform public health and food production for everyday consumers as well as those with life-threatening medical conditions.
BIO and other advanced biofuels groups have long advocated for an investment tax credit (ITC) option for all non-commercial advanced biofuels technologies.
Biotech crops require less tilling of the soil and fewer applications of insecticides. These practices promote environmental sustainability, reduce on-farm fuel use and increase profit margins for U.S. farms.
BIO thanks Sens. Jeff Merkley (D-Ore.), Tom Carper (D-Del.) and Michael Bennet (D-Colo.) for introducing legislation that would make algae and other second-generation biofuels eligible for the cellulosic biofuels production tax credit and create an optional investment tax credit.
“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease and Save Lives” Provides Roadmap for Transformative Policy Changes
3rd annual Worldview Bio-Innovation Scorecard report released at 2011 BIO International Convention showcased the cutting-edge biotech developments shaping the socio-economic progress of countries worldwide
BIO presents Maryland Sen. Nancy J. King (Democrat, District 39) with its 2011 Legislator of the Year Award. Senator King received the award in the Maryland pavilion at the 2011 BIO International Convention taking place in Washington, DC.
BIO announced its endorsement of the “Joint Declaration on Cooperation in the Fight against Doping in Sport” between the World Anti-Doping Agency (WADA) and the International Federation of Pharmaceutical Manufactures and Associations (IFPMA).
BIO President and CEO Jim Greenwood released a statement on the passage of The Leahy-Smith America Invents Act, H.R. 1249, by the House of Representatives.
WASHINGTON, D.C. (Tuesday, June 21, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the Manager’s Amendment to The Leahy-Smith America Invents Act, H.R. 1249.
An amendment offered on the House floor last night would ban the FDA from using any funding to approve the genetically engineered AquAdvantage salmon, beginning next fiscal year.
The 2011 Translational Research Forum, hosted by the Biotechnology Industry Organization (BIO), will explore the challenges and opportunities involved in translating innovative discoveries into usable products that can address some of the world’s most pressing concerns.. The forum will be held at 1-5pm on June 27th at the 2011 BIO International Convention in Washington, D.C. at the Walter E. Washington Convention Center.
The Biotechnology Industry Organization (BIO) is pleased to announce the Buzz of BIO winners for the 2011 BIO International Convention, being held in Washington, D.C. on June 27-30. BIO gave voters the opportunity to choose three buzzworthy new players in the industry with winners chosen in three categories: Healing, Fueling and Feeding.
High-level members of the Obama Administration will gather with leaders from the biopharmaceutical and global health communities at the Partnering for Global Health Forum on June 27 to discuss ways to speed the development of new medical tools — drugs, vaccines and diagnostics — to address the most persistent challenges in global health.
For the third year in a row, the annual BIO International Convention kicks off with a Diversity Summit focused on healthcare issues facing underserved populations.